“I have worked with KOL Communications for many years to help us engage with KOLs internationally to gain advice to support clinical development programmes for a number of different companies. Consistently responsive, professional, thorough and reliable.”

Howard Levy, Chief Medical Officer, Catalyst Biosciences

“KOL Communications provide valuable experience, whether developing the idea or hands on support. Worked on a number of interesting educational programmes across a range of therapy areas.”

Richard Tew, Pharma Country Head and Country President,
Novartis Pharmaceuticals, Australia and New Zealand

“We partnered over a number of years and on a number of initiatives with KOL Communication. In effect, KOL retained full responsibility and accountability for the development of our Global KOL and SAB strategy. This consisted of identification, recruitment and management of all our global KOL’s and SAB’s

Being a biotech company who’s mission is to develop highly innovative and targeted therapies, for numerous oncology indications with high unmet medical need, it was critical that we had the immediate and ongoing input of globally recognised experts.

Without KOL Communications we could not have achieved this and therefore could not have been as successful, in achieving our corporate mission. I wouldn’t hesitate in working with KOL Communications again, nor recommending them to others.”

Brian O’Callaghan, President and CEO, Petrapharma